Shares of AstraZeneca dropped more than 7% yesterday after the Chinese publication Yicai Global reported that dozens of ...

Cassava Sciences (NASDAQ:SAVA) reported better-than-expected earnings with its Q3 2024 financials on Thursday and reaffirmed ...

Financially stable C4 Therapeutics (CCCC) is worth watching for patient investors, but current lack of definitive data poses ...

AstraZeneca is under scrutiny in China — as its top executive there and other personnel are being investigated by authorities ...

Important pieces of the economic puzzle will fall into place this week, starting with inflation and then spending data.

Cardiff has a cash runway of 5-6 quarters, but will need additional funding, potentially leading to significant shareholder ...

Cassava then released the altered data in a press release and investor deck, which led the SEC to allege that the company and ...

The prime minister has taken to talking about “two sides of the same coin” a lot recently – it’s possible to go for growth while doing so in a way that’s good for workers, is his point.

The news led to a stock surge on expectations that forthcoming data for the company’s experimental gene therapy for Rett ...

There are alarm bells everywhere for David Lammy. The foreign secretary has already traveled to the US to court Donald Trump’s team, a trip that some described as a proverbial Nixon to China ...

U.S. Defense Secretary Lloyd Austin called former Israeli Defense Minister Yoav Gallant on Thursday, just two days after he ...

The CSRC welcomes “voices from the market,” financial experts, scholars and the media to supervise the regulator’s work, according to the readout on Sunday. The CRSC will deepen the ...